EVIS Bioscience AG
PrivateLast Round
Pre Seed
Feb 20, 2026
Est. Valuation
$15.03M
Total Funding Raised
$1.31M
Company Overview
EVIS Bioscience AG is a biotechnology company developing innovative gene delivery systems for targeted and personalized medicine.
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EVIS Bioscience AG Comps
Public and private peers based on sector, stage, and business model.
EVIS Bioscience AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Feb 20, 2026 | ||||
| Grant | Dec 1, 2025 |
EVIS Bioscience AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innosuisse | Grant |
| Venture Kick | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 20, 2026
$870K raised in Pre Seed round.
- Dec 1, 2025
$380K grant received from Innosuisse.
EVIS Bioscience AG Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about EVIS Bioscience AG's valuation, stock price, and market status.
